-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2010 to Q3 2024.
- Integrated Biopharma Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2024 was -$56K, a 47.4% decline year-over-year.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$553K, a 398% decline from 2023.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$111K, a 76.1% increase from 2022.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$465K, a 134% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)